Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

SA and Africa must avoid going over the edge
2017-02-26

Description: Prof Hussein Solomon, SA and Africa must avoid going over the edge Tags: Prof Hussein Solomon, SA and Africa must avoid going over the edge

From left are: Prof JM Moosa (Centre for African
Studies, Jawaharlal Nehru University, India),
Prof Hussein Solomon (Senior Professor: Political
Studies and Governance at the UFS),
Prof Virgil Hawkins (Osaka School of International
Public Policy Studies, Osaka University in Japan), and
Prof Ajay Dubey (Centre for African Studies, Jawaharlal Nehru
University, India).
Photo: Jóhann Thormählen

South Africa and the rest of Africa might be standing on the edge of a cliff and therefore conversations are necessary to avoid tipping over. According to Prof Hussein Solomon that was why a conference to address these issues was recently co-hosted by the University of the Free State (UFS).

Prof Solomon, Senior Professor of Political Studies and Governance at the UFS, said the continent and country needed to make the right decisions. “These right choices refer to the correct economic, political, and social policies.”

International delegates attend
Delegates from India, Japan, Zambia, Lesotho and South Africa attended the conference, called A View from the Precipice: Critical Reflections on South Africa and Africa in the 21st Century, on 13 and 14 February 2017 on the Bloemfontein Campus. It was co-hosted by the UFS Department of Political Studies and Governance, Jawaharlal Nehru University (India), Centre for the Engagement on African Peace and Security, Southern African Centre for Collaboration on Peace and Security and Osaka University (Japan).

Prof Solomon said external actors provided a useful mirror as they gave an idea of how Africa and South Africa were viewed from abroad.

Creating a knowledge-sharing forum
“It is not just about sharing knowledge, but creating a forum for sharing knowledge,” said Prof Virgil Hawkins from the Osaka School of International Public Policy Studies.
Prof Hawkins, who is a visiting professor at the UFS, said a conference like this was one of the cornerstones of the relationship between the UFS and Osaka University. Prof Solomon is also a visiting professor at last mentioned university.

Highlights of conference
Prof Solomon said some of the discussions included that “the ANC government is in crisis and is dragging the rest of the country with it”. Another participant said that 80% of the jobs in the next 20 years had not been created yet – which put the relevance of tertiary education in the spotlight.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept